The above article was sent to subscribers in Pharmacy Daily's issue from 30 Mar 12
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Mar 12
NEW training and support for pharmacists delivering services under the Opioid Treatment Program (OTP) in NSW will soon be available under a new partnership between government and industry.
TERRYWHITE Chemmart CEO John Cullity says the planned merger between Chemist Warehouse and Sigma Healthcare would reduce choice in the market and potentially impact smaller businesses negatively.
THE Therapeutic Goods Administration (TGA) has decided that it will not register Lecanemab (LEQEMBI), a medication for people living with mild cognitive impairment and the early stages of Alzheimer’s disease, as “the demonstrated efficacy did not outweigh the safety risks”.
FREE Pharmacy Daily subscription - never miss another story!
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.